摘要
变应性鼻炎和慢性阻塞性肺病是当前两种发病率高、发病人群广泛、病程缠绵且危害显著的呼吸系统疾病。作为有针对性的新一代治疗药物,苯环喹溴铵是我国自主研发的具有自主知识产权的国家一类新药,具有广阔的应用前景。
At present, allergic rhinitis and chronic obstructive pulmonary disease are the two kinds of respiratory diseases, with the features of high incidence, widespread population incidence, long course and remarkable harm. As a new generation of targeted therapeutic drug, bencycloquidium bromide is an independent intellectual property rights and national class of drug that would get broad application prospect.
出处
《中国医药指南》
2016年第4期43-45,共3页
Guide of China Medicine
关键词
苯环喹溴铵
药理
毒理
研究进展
Bencycloquidium bromide
Pharmacological effects
Toxicological information
Research progress
